205 related articles for article (PubMed ID: 19387319)
1. Mechanisms of renal phosphate loss in liver resection-associated hypophosphatemia.
Nafidi O; Lapointe RW; Lepage R; Kumar R; D'Amour P
Ann Surg; 2009 May; 249(5):824-7. PubMed ID: 19387319
[TBL] [Abstract][Full Text] [Related]
2. Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients.
Evenepoel P; Naesens M; Claes K; Kuypers D; Vanrenterghem Y
Am J Transplant; 2007 May; 7(5):1193-200. PubMed ID: 17359508
[TBL] [Abstract][Full Text] [Related]
3. FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation.
Pande S; Ritter CS; Rothstein M; Wiesen K; Vassiliadis J; Kumar R; Schiavi SC; Slatapolsky E; Brown AJ
Nephron Physiol; 2006; 104(1):p23-32. PubMed ID: 16691036
[TBL] [Abstract][Full Text] [Related]
4. Incidence and aetiology of renal phosphate loss in patients with hypophosphatemia in the intensive care unit.
Bech A; Blans M; Telting D; de Boer H
Intensive Care Med; 2013 Oct; 39(10):1785-91. PubMed ID: 23873336
[TBL] [Abstract][Full Text] [Related]
5. Hepatic resection-related hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia.
Salem RR; Tray K
Ann Surg; 2005 Feb; 241(2):343-8. PubMed ID: 15650646
[TBL] [Abstract][Full Text] [Related]
6. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
Bhan I; Shah A; Holmes J; Isakova T; Gutierrez O; Burnett SM; Jüppner H; Wolf M
Kidney Int; 2006 Oct; 70(8):1486-94. PubMed ID: 16941023
[TBL] [Abstract][Full Text] [Related]
7. Elevated fibroblast growth factor 23 levels as a cause of early post-renal transplantation hypophosphatemia.
Han SY; Hwang EA; Park SB; Kim HC; Kim HT
Transplant Proc; 2012 Apr; 44(3):657-60. PubMed ID: 22483462
[TBL] [Abstract][Full Text] [Related]
8. Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation.
Evenepoel P; Meijers BK; de Jonge H; Naesens M; Bammens B; Claes K; Kuypers D; Vanrenterghem Y
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1829-36. PubMed ID: 18922992
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.
Evenepoel P; Meijers B; Viaene L; Bammens B; Claes K; Kuypers D; Vanderschueren D; Vanrenterghem Y
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1268-76. PubMed ID: 20448073
[TBL] [Abstract][Full Text] [Related]
10. Hyperparathyroidism and increased fractional excretion of phosphate predict allograft loss in long-term kidney transplant recipients.
Prakobsuk S; Sirilak S; Vipattawat K; Taweesedt PT; Sumethkul V; Kantachuvesiri S; Disthabanchong S
Clin Exp Nephrol; 2017 Oct; 21(5):926-931. PubMed ID: 27981393
[TBL] [Abstract][Full Text] [Related]
11. Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients.
Saki F; Kassaee SR; Salehifar A; Omrani GHR
BMC Nephrol; 2020 May; 21(1):176. PubMed ID: 32398014
[TBL] [Abstract][Full Text] [Related]
12. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent.
Berndt T; Craig TA; Bowe AE; Vassiliadis J; Reczek D; Finnegan R; Jan De Beur SM; Schiavi SC; Kumar R
J Clin Invest; 2003 Sep; 112(5):785-94. PubMed ID: 12952927
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.
Shigematsu T; Kazama JJ; Yamashita T; Fukumoto S; Hosoya T; Gejyo F; Fukagawa M
Am J Kidney Dis; 2004 Aug; 44(2):250-6. PubMed ID: 15264182
[TBL] [Abstract][Full Text] [Related]
14. The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients.
Irzyniec T; Boryń M; Kasztalska J; Nowak-Kapusta Z; Maciejewska-Paszek I; Grochowska-Niedworok E
Clin Nutr; 2020 Dec; 39(12):3804-3812. PubMed ID: 32386861
[TBL] [Abstract][Full Text] [Related]
15. Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
Muras K; Masajtis-Zagajewska A; Nowicki M
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1901-8. PubMed ID: 24092829
[TBL] [Abstract][Full Text] [Related]
16. Early post-transplantation hypophosphatemia is associated with elevated FGF-23 levels.
Trombetti A; Richert L; Hadaya K; Graf JD; Herrmann FR; Ferrari SL; Martin PY; Rizzoli R
Eur J Endocrinol; 2011 May; 164(5):839-47. PubMed ID: 21335460
[TBL] [Abstract][Full Text] [Related]
17. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
Gutierrez O; Isakova T; Rhee E; Shah A; Holmes J; Collerone G; Jüppner H; Wolf M
J Am Soc Nephrol; 2005 Jul; 16(7):2205-15. PubMed ID: 15917335
[TBL] [Abstract][Full Text] [Related]
19. Hypophosphatemia in acute liver failure of a broad range of etiologies is associated with phosphaturia without kidney damage or phosphatonin elevation.
Zechner C; Adams-Huet B; Gregory B; Neyra JA; Rule JA; Li X; Rakela J; Moe OW; Lee WM;
Transl Res; 2021 Dec; 238():1-11. PubMed ID: 34298149
[TBL] [Abstract][Full Text] [Related]
20. Regulation of phosphate homeostasis by the phosphatonins and other novel mediators.
Shaikh A; Berndt T; Kumar R
Pediatr Nephrol; 2008 Aug; 23(8):1203-10. PubMed ID: 18288501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
